NCT06677632 · NOT YET RECRUITING
Targeting zDHHC Enzymes to Counteract Alzheimer's Disease
This study is investigating a cellular process called S-palmitoylation — essentially how certain proteins get chemically modified by fatty acids in the brain — and whether enzymes called zDHHCs that control this process play a role in Alzheimer's. It is a research study, not a drug trial, focused on profiling these enzymes in human tissue and animal models. No phase is specified, meaning this is early-stage laboratory and translational research.
You may qualify if
- Clinical diagnosis of Alzheimer's Disease
- Age between 18 and 80 years
- Signed informed consent obtained
You're excluded if
- Patients suffering from other neurological diseases;
- Patients with coagulation disorders or in treatment with anticoagulant drugs;
- Patients suffering from dermatological diseases and connective tissue diseases;
- Patients suffering from other organic, psychiatric diseases or laboratory abnormalities could preclude participation or invalidate the study results;
- Inability to give informed consent.
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-11-07